Case ID: 210040
Abstract:
Case
Solution & Analysis for Roche's Acquisition of Genentech by Carliss Y. Baldwin, Bo Becker, Vincent Dessain
Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, the pros and cons of merging the two companies with different cultures, the value of Genentech, and the tactics of a hostile tender offer.
Keywords:
Corporate governance, Corporate strategy, Mergers & acquisitions,Tender offers, Roche's Acquisition of Genentech Case
Solution
Click Here to place your order
OR
Contact us directly at ordercasesolutions@gmail.com if you want to solve the above case.
Search
Categories
- Accounting
- Business & Government Relations
- Business Ethics
- Economics
- Entrepreneurship
- Finance
- General Management
- Human Resource Management
- Information Technology
- International Business
- Marketing
- NACRA Cases List
- Negotiation
- Operations Management
- Organizational Behavior
- Service Management
- Simulations
- Social Enterprise
- Strategy
- Teaching & the Case Method
